COMP <GO>
LUNG vs NYXH // PIOTROSKI F-SCORE QUALITY
Pulmonx Corporation (NASDAQ) VS. Nyxoah SA (NASDAQ) • 15-METRIC TALLY: LUNG 2
— NYXH 0
■ METRIC PARITY
LAST: $2.72 (+5.43%) • MKT CAP: $110.8M
piotroski-score
6/9
LAST: $0.87 (-1.15%) • MKT CAP: $88.1M
piotroski-score
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LUNG VS. NYXH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LUNG | NYXH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -24.15% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -59.30% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -59.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 8.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 6/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.1 | 31.4 | +26.70 | LUNG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $110.8M | $88.1M | $22.7M | LUNG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LUNG REV | NYXH REV | LUNG GROSS % | NYXH GROSS % | LUNG FCF | NYXH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $90.5M | — | 74.2% | — | -$32.8M | — |
| FY 2024 | $83.8M | — | 74.0% | — | -$33.0M | — |
| FY 2023 | $68.7M | — | — | — | -$37.6M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LUNG // BETA —
NYXH // BETA —